Log In
BCIQ
Print this Print this
 

Topical BPM 31510

  Manage Alerts
Collapse Summary General Information
Company Berg LLC
DescriptionUbidecarenone-based small molecule
Molecular Target
Mechanism of Action 
Therapeutic ModalitySmall molecule
Latest Stage of DevelopmentPhase II
Standard IndicationSkin cancer
Indication DetailsTreat skin cancer
Regulatory Designation
Partner

 Product Details
 Archive Items are loading loading
Collapse Summary Deals Information
 Deals Details
Get a free BioCentury trial today